Increasing Engagement in Prison-Based Drug Treatment

提高监狱戒毒治疗的参与度

基本信息

批准号：
7455808
负责人：
WILLIAM M BURDON
金额：
$ 23.12万
依托单位：
UNIVERSITY OF CALIFORNIA LOS ANGELES
依托单位国家：
美国
项目类别：
财政年份：
2005
资助国家：
美国
起止时间：
2005-07-01 至 2011-06-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7455808
关键词：
Adopted Appendix Behavior Behavioral Classification Client Cognitive Collaborations Communities Condition Criminal Justice Drug abuse Drug usage Educational Curriculum Effectiveness Enrollment Environment Event Female Goals Health Personnel Health Services Health Services Research Illicit Drugs Imprisonment Incentives Institution Intervention Letters Measures Meta-Analysis Motivation Numbers Outcome Outpatients Participant Perception Performance Pharmaceutical Preparations Population Prisons Procedures Process Protocols documentation Provider Psychological reinforcement Punishment Purpose Randomized Range Rate Readiness Research Research Design Research Personnel Risk Role Schedule Services Specific qualifier value Standards of Weights and Measures Substance abuse problem System Testing Washington Week base contingency management correctional system design improved innovation male offender programs psychosocial reincarceration research study response treatment organization treatment program

项目摘要

DESCRIPTION (provided by applicant): The UCLA Integrated Substance Abuse Programs (ISAP), in collaboration with CiviGenics, Inc. and the Washington State Department of Corrections, is proposing a 4-year health services study that will seek to (1) test the impact of a behavioral reinforcement intervention on inmate engagement in prison-based substance abuse treatment (thereby improving both psychosocial functioning over the course of treatment and post-release outcomes [e.g., decreased drug use, reincarceration]), and (2) assess the process by which this evidence-based innovation is implemented and sustained within prison-based treatment programs. Male and female inmates (240) enrolled in 12-week prison-based intensive outpatient (IOP) treatment will be randomly assigned to one of two programs (conditions): Behavioral Reinforcement (BR) (experimental) and Standard Treatment (ST) (comparison). Inmates assigned to the BR programs will receive behavioral reinforcement contingent upon their attendance at and participation in regularly scheduled program activities and completion of assigned treatment-related tasks. Inmates assigned to the ST programs will receive standard IOP treatment services. The study will also assess the implementation of the behavioral reinforcement intervention within the treatment programs, measure organizational readiness for change both prior to the intervention and after it is completed, and determine if the intervention is sustained following completion of the study. The study has the following primary aims: (1) Increase client engagement in prison-based substance abuse treatment and improve client's psychosocial functioning over the course of treatment using behavioral reinforcement; (2) Assess the impact of behavioral reinforcement on prison-based treatment, participants' entrance into and retention in community-based treatment following release from prison, post-incarceration illicit drug use, and 9-month return-to-custody rates; and (3) Assess possible differential effects of the behavioral reinforcement intervention on a male and a female prison based substance abuse treatment population. The study has the following secondary aims: (4) Qualitatively assess the process by which this evidence-based innovation (behavioral reinforcement) is implemented within a prison-based treatment program; (5) Quantitatively assess organizational readiness for change on the part of the treatment organization and the larger institutional organization prior to the introduction of the behavioral reinforcement intervention and after the intervention is complete; and (6) Determine whether or not the behavioral reinforcement intervention is sustained as a normal part of the in-prison treatment curriculum following the end of the research study.

描述（由申请人提供）：与Civigenics，Inc。和华盛顿州惩教局合作的UCLA综合药物滥用计划（ISAP）正在提议一项为期4年的卫生服务研究，该研究将寻求（1）测试行为加强干预对囚犯参与基于监狱的药物滥用治疗的影响（从而改善了治疗过程中的社会心理功能和释放后结果[在基于监狱的治疗计划中实施并维持这种基于证据的创新。在基于12周的监狱强化门诊（IOP）治疗中，男性和女性囚犯（240）将随机分配给两个程序之一（条件）：行为加强（BR）（BR）（实验）和标准治疗（ST）（比较））。分配给BR计划的囚犯将获得行为强化，这取决于他们参加并参加定期计划的计划活动并完成指定的与治疗相关的任务。分配给ST计划的囚犯将获得标准的IOP治疗服务。该研究还将评估治疗计划中行为强化干预的实施，在干预之前和完成后衡量组织的准备就绪，并确定研究完成后是否持续了干预措施。该研究具有以下主要目的：（1）增加客户参与基于监狱的药物滥用治疗，并在治疗过程中使用行为强化改善客户的心理社会功能；（2）评估行为强化对监狱待遇的影响，参与者从监狱释放后进入社区治疗，监禁后非法药物使用以及9个月的重返监护率的影响；（3）评估行为加强干预对男性和女性监狱滥用药物治疗人群的可能差异影响。该研究具有以下次要目的：（4）定性评估在基于监狱的治疗计划中实施这种基于证据的创新（行为加强）的过程；（5）在引入行为强化干预之前和干预完成后，定量评估治疗组织和较大机构组织变更的组织准备情况；（6）确定研究结束后，行为加强干预是否作为监狱内治疗课程的正常部分维持。